Botox [botulinum toxin A] for non-surgical lateral release in patellofemoral pain.

Trial Profile

Botox [botulinum toxin A] for non-surgical lateral release in patellofemoral pain.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 17 May 2011

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Musculoskeletal pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 May 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 20 May 2009 Planned number of patients changed from 20 to 5 as reported by ClinicalTrials.gov.
    • 17 Feb 2009 Planned end date changed from 1 Jun 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top